Olli Silvennoinen

9PUBLICATIONS
38CO-AUTHORS
AutoimmunityGene expression (incl. microarray and other genome-wide approaches)Molecular targetsHaematologyHaematological tumours
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (9)

|Apr 17, 2026
A rare JAK2 mutation associated with adult-onset Still's disease and exacerbated vaccine-induced innate immune response.

|Jan 28, 2026
Heritability and Transcriptional Impact of JAK3, STAT5A and STAT6 Variants in a Tyrolean Family.

Hye Kyung Lee, Teemu Haikarainen, Yasemin Caf

|Jan 04, 2026
Pharmacological targeting of the JAK-STAT pathway: new concepts and emerging indications.

Teemu Haikarainen, Anniina T Virtanen, Benjamin F Cravatt

|Nov 11, 2025
JAK2/JAK2V617F heterodimers activate STAT1 and AhR to promote thrombocytosis.

Radek C Skoda, Olli Silvennoinen

|Apr 30, 2025
Clonal hematopoiesis is associated with distinct rheumatoid arthritis phenotypes.

Emil Hiitola, Juuso Korhonen, Heidi Kokkonen

|Mar 08, 2024
Molecular basis of JAK2 activation in erythropoietin receptor and pathogenic JAK2 signaling.

Bobin George Abraham, Teemu Haikarainen, Joni Vuorio

Pageof 2

Frequent Collaborators

3 joint publications

Anniina T Virtanen

2 joint publications

Lothar Hennighausen

2 joint publications

Teemu Haikarainen

2 joint publications

Priscilla A Furth